FDA Adverse Event Malfunction Summary report: N

ALINITY I FREE T4 REAGENT KIT

MDR report key: 20062872 · Received August 26, 2024

Report

Report Number
3005094123-2024-00443
Event Type
Malfunction
Date Received
August 26, 2024
Date of Event
August 6, 2024
Report Date
October 4, 2024
Manufacturer
ABBOTT IRELAND DIAGNOSTICS DIVISION
Product Code
CEC
UDI-DI
00380740121815
PMA / PMN Number
K173122
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

AN EVALUATION IS IN PROCESS. A FOLLOW UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. SECTION A1 PATIENT IDENTIFIER COMPLETE SID : (B)(6). ALL AVAILABLE PATIENT INFORMATION WAS INCLUDED. ADDITIONAL PATIENT DETAILS ARE NOT AVAILABLE.

Additional Manufacturer Narrative · 0

THE COMPLAINT INVESTIGATION INCLUDED A REVIEW OF DATA AND INFORMATION PROVIDED BY THE CUSTOMER, SEARCH FOR SIMILAR COMPLAINTS, TICKET TRENDING REVIEW, DEVICE HISTORY RECORD REVIEW, AND LABELING REVIEW. ADDITIONALLY, IN-HOUSE TESTING WAS PERFORMED. RETURN TESTING WAS NOT COMPLETED AS RETURNS WERE NOT AVAILABLE. DATA AND INFORMATION PROVIDED BY THE CUSTOMER WERE REVIEWED AND SUPPORT THE COMPLAINT ISSUE. A SEARCH FOR SIMILAR COMPLAINTS DID IDENTIFY AN INCREASE IN COMPLAINT ACTIVITY, HOWEVER, NO RELATED TRENDS WERE IDENTIFIED REGARDING COMMONALITIES FOR LOT NUMBER 59141UD00 AND ISSUE FOR THE PRODUCT. ADDITIONALLY, IN-HOUSE PERFORMANCE TESTING WAS COMPLETED WHICH INDICATES THE PRODUCT IS PERFORMING AS EXPECTED. THE DEVICE HISTORY RECORD REVIEW DID NOT IDENTIFY ANY NONCONFORMANCES, POTENTIAL NONCONFORMANCES OR DEVIATIONS ASSOCIATED WITH LOT NUMBER 59141UD00 AND THE COMPLAINT ISSUE. LABELING WAS REVIEWED AND ADEQUATELY ADDRESSES THE CUSTOMER¿S ISSUE. BASED ON THE INVESTIGATION, NO SYSTEMIC ISSUE OR DEFICIENCY OF THE ALINITY I FREE T4 FOR LOT 59141UD00 WAS IDENTIFIED.

Description of Event or Problem · 0

THE CUSTOMER REPORTED A FALSELY ELEVATED ALINITY I FREE T4 (FT4) RESULT ON A PATIENT. THE FOLLOWING RESULTS WERE PROVIDED: (B)(6) 2024 SID (B)(6) FT4 = >5.00 NG/DL; FT3 = 2.62 PG/ML; TSH = 0.5780 UIU/ML. REPEATED ON (B)(6) 2024: FT4 = 1.03 NG/DL; FT3 = 2.25 PG/ML; TSH = 0.5799 UIU/ML. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

Description of Event or Problem · 0

THE CUSTOMER REPORTED A FALSELY ELEVATED ALINITY I FREE T4 (FT4) RESULT ON A PATIENT. THE FOLLOWING RESULTS WERE PROVIDED: (B)(6) 2024 SID (B)(6) FT4 = >5.00 NG/DL; FT3 = 2.62 PG/ML; TSH = 0.5780 UIU/ML. REPEATED ON (B)(6) 2024: FT4 = 1.03 NG/DL; FT3 = 2.25 PG/ML; TSH = 0.5799 UIU/ML. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1194244 ALINITY I FREE T4 REAGENT KIT RADIOIMMUNOASSAY, FREE THYROXINE CEC ABBOTT IRELAND DIAGNOSTICS DIVISION 59141UD00 00380740121815

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown ALNTY I PROCESSING MODU, 03R65-01, (B)(6) | ALNTY I PROCESSING MODU, 03R65-01, (B)(6)